Sorafenib

1 view

Skip to first unread message

Julian Thomas

unread,

Jun 3, 2014, 8:11:59 AM6/3/14

to bioin...@googlegroups.com, Bioinforma...@googlegroups.com, Bioinfo...@googlegroups.com, bioinfo...@yahoogroups.com, bioiso...@gmail.com, Biosol...@yahoogroups.com, CoE...@googlegroups.com, DrugD...@googlegroups.com, Talk-B...@googlegroups.com, theoretical-mo...@googlegroups.com, BISA Bioinformatics, sci.bio.evolution moderation account

Sorafenib (co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar),[1] is a drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma) and advanced primary liver cancer (hepatocellular carcinoma).

http://bio-solutions.blogspot.in/2011/11/sorafenib.html

Cheers,
Julian Thomas

Reply all

Reply to author

Forward

0 new messages